Powered by: Motilal Oswal
2026-02-27 11:24:23 am | Source: Accord Fintech
Dhampur Bio Organics gains on getting nod to incorporate subsidiary in UAE
Dhampur Bio Organics gains on getting nod to incorporate subsidiary in UAE

Dhampur Bio Organics is currently trading at Rs. 103.25, up by 1.75 points or 1.72% from its previous closing of Rs. 101.50 on the BSE.

The scrip opened at Rs. 103.00 and has touched a high and low of Rs. 105.80 and Rs. 101.60 respectively. So far 2856 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 115.00 on 30-Jan-2026 and a 52 week low of Rs. 58.11 on 13-Mar-2025.

Last one week high and low of the scrip stood at Rs. 107.40 and Rs. 97.15 respectively. The current market cap of the company is Rs. 685.45 crore.

The promoters holding in the company stood at 50.65%, while Institutions and Non-Institutions held 1.24% and 48.10% respectively.

Dhampur Bio Organics has received approval to incorporation a wholly owned subsidiary in United Arab Emirates (UAE). With this, the company is proposing to make initial investment of AED 73,45,000 ($2 million) in the proposed wholly owned subsidiary. The proposed subsidiary will be engaged in trading, distribution, packaging of Sugar and other FMCG products, futures in sugar and allied products. The board of directors of the company at its meeting held on February 26, 2026, has inter-alia approved the same.

The incorporation is being done in compliance with the applicable laws in the UAE and as per the Foreign Exchange Management Rules, Regulations and Directions issued by the Reserve Bank of India, the Companies Act, 2013 and other laws as applicable.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here